These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10160575)
1. Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol. Bentkover JD; Baker AM; Kaplan H Pharmacoeconomics; 1994 Apr; 5(4):335-42. PubMed ID: 10160575 [TBL] [Abstract][Full Text] [Related]
2. A decision analysis model in the evaluation of NSAIDs in a managed care setting: a case study. Brixner DI Med Interface; 1994 Nov; 7(11):145-50. PubMed ID: 10138701 [TBL] [Abstract][Full Text] [Related]
3. A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa. Roth SH; Tindall EA; Jain AK; McMahon FG; April PA; Bockow BI; Cohen SB; Fleischmann RM Arch Intern Med; 1993 Nov; 153(22):2565-71. PubMed ID: 8239849 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. Morgan GJ; Poland M; DeLapp RE Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK. Moore A; Phillips C; Hunsche E; Pellissier J; Crespi S Pharmacoeconomics; 2004; 22(10):643-60. PubMed ID: 15244490 [TBL] [Abstract][Full Text] [Related]
6. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Eversmeyer W; Poland M; DeLapp RE; Jensen CP Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers. Agrawal NM; Caldwell J; Kivitz AJ; Weaver AL; Bocanegra TS; Ball J; Dhadda S; Hurley S; Hancock L Clin Ther; 1999 Apr; 21(4):659-74. PubMed ID: 10363732 [TBL] [Abstract][Full Text] [Related]
8. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis. Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDs. Watson DJ; Harper SE; Zhao PL; Bolognese JA; Simon TJ MedGenMed; 2001 Nov; 3(4):6. PubMed ID: 11965201 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs. Chan FK; Sung JJ; Ching JY; Wu JC; Lee YT; Leung WK; Hui Y; Chan LY; Lai AC; Chung SC Aliment Pharmacol Ther; 2001 Jan; 15(1):19-24. PubMed ID: 11136274 [TBL] [Abstract][Full Text] [Related]
11. Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands. Al MJ; Maniadakis N; Grijseels EW; Janssen M Value Health; 2008; 11(4):589-99. PubMed ID: 18194404 [TBL] [Abstract][Full Text] [Related]
12. Nabumetone: new preparation. Just another NSAID. Prescrire Int; 2000 Apr; 9(46):43-6. PubMed ID: 11503785 [TBL] [Abstract][Full Text] [Related]
13. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis. Roth SH Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889 [TBL] [Abstract][Full Text] [Related]
14. How much faith can we have in pharmacoeconomic analyses? Hatoum HT; Kong SX Pharmacoeconomics; 1994 Dec; 6(6):584-6. PubMed ID: 10155288 [No Abstract] [Full Text] [Related]
15. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions. Davis R; Yarker YE; Goa KL Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992 [TBL] [Abstract][Full Text] [Related]
16. Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs. van Dieten HE; Korthals-de Bos IB; van Tulder MW; Lems WF; Dijkmans BA; Boers M Ann Rheum Dis; 2000 Oct; 59(10):753-9. PubMed ID: 11005773 [TBL] [Abstract][Full Text] [Related]
17. Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis. The impact on costs and outcomes in the UK. McCabe CJ; Akehurst RL; Kirsch J; Whitfield M; Backhouse M; Woolf AD; Scott DL; Emery P; Haslock I Pharmacoeconomics; 1998 Aug; 14(2):191-9. PubMed ID: 10186459 [TBL] [Abstract][Full Text] [Related]
18. The economic consequences of NSAID-induced gastropathy in the United Kingdom and commentary on the article by G. de Pouvourville. Knill-Jones RP Scand J Rheumatol Suppl; 1992; 96():59-62. PubMed ID: 1439626 [TBL] [Abstract][Full Text] [Related]
19. Nabumetone compared with indomethacin in the treatment of osteoarthritis in general practice. Carle WK; Wade AG; Kill DC; Poland M J Rheumatol Suppl; 1992 Nov; 36():58-62. PubMed ID: 1474536 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee]. Gijón Baños J Med Clin (Barc); 1997 Jun; 109(4):130-4. PubMed ID: 9289526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]